However, it should be noted that we could not find in vitro evidence supporting a synergistic effect of miR-122 mimic oligonucleotides with sorafenib in SerpinB3-overexpressing HCC cells, leading us to speculate that their combination might not be effective in SerpinB3-positive HCC patients. Here, SERPINB3 is linked to hepatocellular carcinoma.